Armata Pharmaceuticals (ARMP) Operating Expenses (2013 - 2026)

Armata Pharmaceuticals (ARMP) has 14 years of Operating Expenses data on file, last reported at $9.6 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 10.27% year-over-year to $9.6 million; the trailing twelve-month figure through Mar 2026 stood at $42.4 million (down 5.92% YoY), and the FY2025 full-year result was $41.5 million, down 12.75% from the prior year.
• Operating Expenses fell to $9.6 million in Q1 2026, from $14.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $14.9 million in Q4 2025 to a low of $8.7 million in Q1 2025.
• A 5-year average of $11.0 million and a median of $11.1 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses jumped 61.7% in 2022 and slipped 29.81% in 2025, its largest moves.
• Tracing ARMP's Operating Expenses over 5 years: stood at $11.4 million in 2022, then declined by 2.39% to $11.1 million in 2023, then climbed by 6.01% to $11.8 million in 2024, then advanced by 26.62% to $14.9 million in 2025, then slumped by 35.78% to $9.6 million in 2026.
• Business Quant data shows ARMP's Operating Expenses at $9.6 million in Q1 2026, $14.9 million in Q4 2025, and $8.9 million in Q3 2025.